Relation of vitamin D and parathyroid hormone to cardiac biomarkers and to left ventricular mass (from the Cardiovascular Health Study).

[1]  W. März,et al.  Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. , 2012, Cardiovascular research.

[2]  W. Paulus,et al.  Vitamin D in Relation to Myocardial Structure and Function after Eight Years of Follow-Up: The Hoorn Study , 2012, Annals of Nutrition and Metabolism.

[3]  B. Kestenbaum,et al.  Vitamin D, parathyroid hormone, and cardiovascular events among older adults. , 2011, Journal of the American College of Cardiology.

[4]  B. Horne,et al.  Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? , 2011, American heart journal.

[5]  E. Rimm,et al.  Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. , 2011, American heart journal.

[6]  D. Lawlor,et al.  Associations of vitamin D, parathyroid hormone and calcium with cardiovascular risk factors in US adolescents , 2010, Heart.

[7]  M. Zhan,et al.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults. , 2010, JAMA.

[8]  W. März,et al.  Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study. , 2010, Clinica chimica acta; international journal of clinical chemistry.

[9]  C. Feldstein,et al.  Long-Term Effects of Parathyroidectomy on Hypertension Prevalence and Circadian Blood Pressure Profile in Primary Hyperparathyroidism , 2010, Clinical and experimental hypertension.

[10]  S. Silverberg,et al.  Cardiac structure and diastolic function in mild primary hyperparathyroidism. , 2010, The Journal of clinical endocrinology and metabolism.

[11]  J. Gottdiener,et al.  Dynamic cardiovascular risk assessment in elderly people. The role of repeated N-terminal pro-B-type natriuretic peptide testing. , 2010, Journal of the American College of Cardiology.

[12]  C. Held,et al.  Abstract 828: Plasma Parathyroid Hormone and Risk of Congestive Heart Failure in the Community , 2009 .

[13]  B. Kestenbaum,et al.  25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. , 2009, Journal of the American Society of Nephrology : JASN.

[14]  K. Schlüter,et al.  Parathyroid hormone improves contractile performance of adult rat ventricular cardiomyocytes at low concentrations in a non-acute way. , 2009, Cardiovascular research.

[15]  L. Mosekilde,et al.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. , 2009, The Journal of clinical endocrinology and metabolism.

[16]  S. Browning,et al.  Bone Markers Predict Cardiovascular Events in Chronic Kidney Disease , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[17]  S. Russell,et al.  Reduced kidney function as a risk factor for incident heart failure: the atherosclerosis risk in communities (ARIC) study. , 2007, Journal of the American Society of Nephrology : JASN.

[18]  Daniel Levy,et al.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death. , 2004, The New England journal of medicine.

[19]  J. Sundsfjord,et al.  Parathyroid hormone and left ventricular hypertrophy. , 2003, European heart journal.

[20]  N. García de la Torre,et al.  Parathyroid adenomas and cardiovascular risk. , 2003, Endocrine-related cancer.

[21]  A. Piovesan,et al.  Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy , 1999, Clinical endocrinology.

[22]  R. Kronmal,et al.  Utility of new electrocardiographic models for left ventricular mass in older adults. The Cardiovascular Health Study Collaborative Research Group. , 1996, Hypertension.

[23]  M. Cushman,et al.  Laboratory methods and quality assurance in the Cardiovascular Health Study. , 1995, Clinical chemistry.

[24]  R. Kronmal,et al.  The Cardiovascular Health Study: design and rationale. , 1991, Annals of epidemiology.

[25]  G. Nijpels,et al.  Vitamin D deficiency and myocardial structure and function in older men and women: the Hoorn study. , 2010, Journal of endocrinological investigation.

[26]  A. Levin,et al.  Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. , 2007, Kidney international.

[27]  Y. Arad,et al.  Serum concentration of calcium, 1,25 vitamin D and parathyroid hormone are not correlated with coronary calcifications. An electron beam computed tomography study , 1998, Coronary artery disease.

[28]  P. Parfrey,et al.  Risk factors for the development of left ventricular hypertrophy in a prospectively followed cohort of dialysis patients. , 1994, Journal of the American Society of Nephrology : JASN.

[29]  H. S. Klopfenstein,et al.  Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. , 1992, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[30]  M. H. Gault,et al.  Left ventricular hypertrophy in end-stage renal disease. , 1988, Nephron.